The PRODIGY Study at a Glance
Download Now
The PRODIGY Trial
PRODIGY (PRediction of Opioid‐induced respiratory Depression In patients monitored by capnoGraphY) is a prospective, multi‐center, international cohort study to assess the potential for respiratory compromise (RC) risk assessment in patients receiving opioids on the hospital general care floor also examining the value of continuous capnography and oximetry monitoring.
-
-
Infographic: Learn About the PRODIGY Study
Learn More
-
Video: PRODIGY Animation
Watch Video
-
Respiratory Compromise PRODIGY FAQ
Download Now
-
Complimentary PRODIGY Risk Prediction Tool
Download Now
-
Interviews on Respiratory Compromise
Thought leaders discuss why they believe respiratory compromise is an important safety issue needing better solutions.
Watch Video
-
Video: Evidence Summary of PRODIGY Study
Watch Video
-
PRODIGY Podcast
Dr. Ludwig Lin interviews Dr. Ashish Khanna on the PRODIGY study, awarded a Star Research Presentation at the SCCM conference.
LOG IN TO LISTEN
-
Explore Remote Continuous Monitoring Solutions
Learn More -
White Paper: Who Are Your High Risk Respiratory Patients & How to Assess Them
Download Now
-
Video: Evidence Summary PRODIGY Seeking Answers
Watch Video
-
CSM Khanna Seeking Answers from PRODIGY Clinical Summary
Download Now
-
Cost efficiency and patient safety
Download Now
-
Loading, please wait
Error - something went wrong!
Subscribe to the Monthly Respiratory Compromise Newsletter
Thank you!
-
BACK TO RESPIRATORY COMPROMISE RESOURCES
VIEW ALL
